JEWEL SAWYER: Open Payments
NPI 1528346152 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 88 payments from 11 companies in 2025. Trend: 2023 $17,323 · 2024 $2,161 · 2025 $2,262
Food & beverage: $2,262
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 36 | $885 |
| Gilead Sciences, Inc. | 25 | $838 |
| Merck Sharp & Dohme LLC | 6 | $135 |
| Theratechnologies Inc. | 5 | $121 |
| Lilly USA, LLC | 4 | $76 |
| Verity Pharmaceuticals Inc. | 4 | $68 |
| Novo Nordisk Inc | 3 | $52 |
| EMD Serono, Inc. | 2 | $33 |
| Napo Pharmaceuticals Inc | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
Products named: CABENUVA, APRETUDE, DOVATO, EGRIFTA, PIFELTRO, RUKOBIA, Tlando, MOUNJARO.
Industry payments across GA — which companies pay providers there.
